🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 17% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

3 Softgel(s) Serving Size
33 Servings
Fat/Fatty Acid Product Type
17% Evidence Coverage

Supplement Facts — Evidence Check

Calories
30 Calorie(s)
Total Fat
3 g (5% DV)
4 mg (27% DV)
✅ Within RDA (0.3× RDA of 15 mg) 📚 177 studies (Tier A: 3, B: 90)
RDA 15mg This product: 4mg UL 1000mg
Omega-6 Fatty Acids
Omega-9 Fatty Acids

Other Ingredients

Fish Oil Evening Primrose Oil Flaxseed Oil Gelatin Glycerin Water

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (99% of products) Structure/Function (86% of products) Nutrient (79% of products) Qualified Health (13% of products) Approved Health (2% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Take 3 softgels daily

Directions: As a dietary supplement for adults, take 3 softgels daily with a meal or as directed by a healthcare professional.

⚠️ Warnings & Precautions

Contains Fish.

Warning: If you are pregnant, nursing, or taking any medications, consult your doctor before use.

Do not use if seal under cap is broken or missing.

Keep out of reach of children.

🧪 Formulation Notes

Helps support brain, heart, joint and skin health

Provides a diverse selection of major omega fatty acids Fish oil Evening primrose oil Flaxseed oil

Additional Information

Since 1960 Nutrition+

Store at room temperature.

Discover the Bronson difference To reorder: www.bronsonvitamins.com

Product Details

UPC / SKU 7 16563 12501 1
DSLD Entry Date 2021-12-18
Product Type Fat/Fatty Acid
Form Softgel Capsule
Brand Bronson
DSLD ID 257456
Data Updated 2026-04-11

Research Evidence

495 Research Sources
56 Avg Quality Score
222 Meta Analysis
104 Clinical Trial
72 Rct
69 Systematic Review
11 Guideline
5 Cochrane Review
5 Regulatory Source
3 Narrative Review
1 Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
View all evidence for Omega 3 →

Compare Similar Products

View all Omega 3 products →